Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0P8IX
|
|||
Former ID |
DNC011468
|
|||
Drug Name |
1-Hydroxy-10H-anthracen-9-one
|
|||
Synonyms |
1-Hydroxyanthrone; 1-Hydroxy-9-anthrone; 1715-81-7; 1-Hydroxy-10H-anthracen-9-one; 9-Anthrone, 1-hydroxy-; 9-Anthronol; BRN 3530761; CHEMBL123161; 1-HYDROXY-9,10-DIHYDROANTHRACEN-9-ONE; hydroxyanthrone; AC1L45BO; SCHEMBL1204733; CTK4D3980; DTXSID10169112; 1-Hydroxyanthracen-9(10H)-one; MolPort-022-384-226; 9(10H)-Anthracenone,1-hydroxy-; ZINC6117388; BDBM50060879; AKOS022650101; LS-20754
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C14H10O2
|
|||
Canonical SMILES |
C1C2=C(C(=CC=C2)O)C(=O)C3=CC=CC=C31
|
|||
InChI |
1S/C14H10O2/c15-12-7-3-5-10-8-9-4-1-2-6-11(9)14(16)13(10)12/h1-7,15H,8H2
|
|||
InChIKey |
AXHRXVXCOMMNLG-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 1715-81-7
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Arachidonate 5-lipoxygenase (5-LOX) | Target Info | Inhibitor | [1] |
BioCyc | Aspirin-triggered lipoxin biosynthesis | |||
Resolvin D biosynthesis | ||||
Leukotriene biosynthesis | ||||
Lipoxin biosynthesis | ||||
Aspirin triggered resolvin D biosynthesis | ||||
Aspirin triggered resolvin E biosynthesis | ||||
KEGG Pathway | Arachidonic acid metabolism | |||
Metabolic pathways | ||||
Serotonergic synapse | ||||
Ovarian steroidogenesis | ||||
Toxoplasmosis | ||||
NetPath Pathway | IL4 Signaling Pathway | |||
Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
WikiPathways | Vitamin D Receptor Pathway | |||
Arachidonic acid metabolism | ||||
Eicosanoid Synthesis | ||||
Selenium Micronutrient Network |
References | Top | |||
---|---|---|---|---|
REF 1 | Simple analogues of anthralin: unusual specificity of structure and antiproliferative activity. J Med Chem. 1997 Nov 7;40(23):3773-80. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.